Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
VCU Medical Center
mi
from
Richmond, VA
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
West Virginia University - Ruby Memorial Hospital
mi
from
Morgantown, WV
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
West Virginia University - Ruby Memorial Hospital
mi
from
Morgantown, WV
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Medical College of Wisconsin
mi
from
Milwakee, WI
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Medical College of Wisconsin
mi
from
Milwakee, WI
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Stanford University
mi
from
Palo Alto, CA
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Boston Med Ctr
mi
from
Boston, MA
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Henry Ford Health System
mi
from
Detroit, MI
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated:  5/4/2016
University of Alberta
mi
from
Edmonton,
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Status: Enrolling
Updated: 5/4/2016
University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Status: Enrolling
Updated:  5/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Status: Enrolling
Updated: 5/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
An Open-Label Controlled Study of Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome
Status: Enrolling
Updated:  5/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
An Open-Label Controlled Study of Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome
Status: Enrolling
Updated: 5/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE
Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE
Status: Enrolling
Updated:  5/10/2016
University at Buffalo Neurosurgery
mi
from
Buffalo, NY
Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE
Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE
Status: Enrolling
Updated: 5/10/2016
University at Buffalo Neurosurgery
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
Massachusetts General Hospital
mi
from
Boston, MA
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
Skulpt, Inc
mi
from
Boston, MA
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
Skulpt, Inc
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Changing Talk to Reduce Resistiveness to Care
Changing Talk to Reduce Resistiveness to Care
Status: Enrolling
Updated:  5/10/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Changing Talk to Reduce Resistiveness to Care
Changing Talk to Reduce Resistiveness to Care
Status: Enrolling
Updated: 5/10/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated:  5/11/2016
Clinical Research Facility
mi
from
Mountlake Terrace, WA
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 5/11/2016
Clinical Research Facility
mi
from
Mountlake Terrace, WA
Click here to add this to my saved trials
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated:  5/11/2016
mi
from
Liege,
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 5/11/2016
mi
from
Liege,
Click here to add this to my saved trials
Early Propranolol After Traumatic Brain Injury: Phase II
A Phase II, Dose Escalation, Single Center Study on the Effects of Early Propranolol on Heart Rate, Blood Pressure, and Cerebral Perfusion Pressure in Subjects Who Present With Moderate to Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  5/12/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Early Propranolol After Traumatic Brain Injury: Phase II
A Phase II, Dose Escalation, Single Center Study on the Effects of Early Propranolol on Heart Rate, Blood Pressure, and Cerebral Perfusion Pressure in Subjects Who Present With Moderate to Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 5/12/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Feet First: Promoting Physical Activity Among People With Diabetes Mellitus and Insensate Feet
Feet First: Increasing Activity Without Increasing the Risk of Foot Ulcers in People With Diabetes and Insensate Feet
Status: Enrolling
Updated:  5/12/2016
University of Missouri
mi
from
Columbia, MO
Feet First: Promoting Physical Activity Among People With Diabetes Mellitus and Insensate Feet
Feet First: Increasing Activity Without Increasing the Risk of Foot Ulcers in People With Diabetes and Insensate Feet
Status: Enrolling
Updated: 5/12/2016
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery
Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery
Status: Enrolling
Updated:  5/17/2016
Emory University Hospital Midtown
mi
from
Atlanta, GA
Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery
Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery
Status: Enrolling
Updated: 5/17/2016
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Arkansas Children's Hospital
mi
from
Little Rock, AR
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Cook Children's Health Care System
mi
from
Fort Worth, TX
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Cook Children's Health Care System
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Gillette Children's Specialty Healthcare
mi
from
St. Paul, MN
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Gillette Children's Specialty Healthcare
mi
from
St. Paul, MN
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Loma Linda University
mi
from
Loma Linda, CA
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Loma Linda University
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Rehabilitation Medicine Department, University of Miami, Miller School of Medicine
mi
from
Miami, FL
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Rehabilitation Medicine Department, University of Miami, Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
The Medical College of Wisconsin Department of Physical Medicine and Rehabilitation
mi
from
Milwaukee, WI
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
The Medical College of Wisconsin Department of Physical Medicine and Rehabilitation
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Ohio State University
mi
from
Columbus, OH
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
TIRR Memorial Hermann
mi
from
Houston, TX
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
TIRR Memorial Hermann
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
University of Utah, Division of PM&R
mi
from
Salt Lake City, UT
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
University of Utah, Division of PM&R
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Vanderbilt University Medical Center, Department of Pediatrics
mi
from
Nashville, TN
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Vanderbilt University Medical Center, Department of Pediatrics
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated:  5/17/2016
Wayne State University, School of Medicine
mi
from
Dearborn, MI
Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Status: Enrolling
Updated: 5/17/2016
Wayne State University, School of Medicine
mi
from
Dearborn, MI
Click here to add this to my saved trials
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
Columbia SMA Project: 4-AP as a Potential SMA Therapeutic Agent and Biological Mechanisms of Action
Status: Enrolling
Updated:  5/17/2016
Columbia University Medical Center
mi
from
New York, NY
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
Columbia SMA Project: 4-AP as a Potential SMA Therapeutic Agent and Biological Mechanisms of Action
Status: Enrolling
Updated: 5/17/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Acupuncture for Sedation in the Intensive Care Unit (ICU)
Acupuncture for Sedation in the Intensive Care Unit
Status: Enrolling
Updated:  5/18/2016
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Acupuncture for Sedation in the Intensive Care Unit (ICU)
Acupuncture for Sedation in the Intensive Care Unit
Status: Enrolling
Updated: 5/18/2016
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
Status: Enrolling
Updated:  5/18/2016
OSF St. Francis Medical Center
mi
from
Peoria, IL
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
Status: Enrolling
Updated: 5/18/2016
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Bone Health in Facioscapulohumeral Muscular Dystrophy
Bone Health in Facioscapulohumeral Muscular Dystrophy: A Cross-sectional Study
Status: Enrolling
Updated:  5/18/2016
Kennedy Krieger Institute, Johns Hopkins School of Medicine
mi
from
Baltimore, MD
Bone Health in Facioscapulohumeral Muscular Dystrophy
Bone Health in Facioscapulohumeral Muscular Dystrophy: A Cross-sectional Study
Status: Enrolling
Updated: 5/18/2016
Kennedy Krieger Institute, Johns Hopkins School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bone Health in Facioscapulohumeral Muscular Dystrophy
Bone Health in Facioscapulohumeral Muscular Dystrophy: A Cross-sectional Study
Status: Enrolling
Updated:  5/18/2016
Concord Hospital Neurology Department, Hospital Road, Concord NSW 2139
mi
from
Sydney,
Bone Health in Facioscapulohumeral Muscular Dystrophy
Bone Health in Facioscapulohumeral Muscular Dystrophy: A Cross-sectional Study
Status: Enrolling
Updated: 5/18/2016
Concord Hospital Neurology Department, Hospital Road, Concord NSW 2139
mi
from
Sydney,
Click here to add this to my saved trials
Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
Phase IV - A Trial of Xyrem in the Treatment of Chronic Fatigue Syndrome.
Status: Enrolling
Updated:  5/18/2016
UMDNJ - Pain & Fatigue Study Center, ADMC 1618
mi
from
Newark, NJ
Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
Phase IV - A Trial of Xyrem in the Treatment of Chronic Fatigue Syndrome.
Status: Enrolling
Updated: 5/18/2016
UMDNJ - Pain & Fatigue Study Center, ADMC 1618
mi
from
Newark, NJ
Click here to add this to my saved trials
Pain in Traumatic Brain Injury - Basile, MD
The Role of Persistent Pain on Neuro Psychological Functioning and Community Integration in Traumatic Brain Injury
Status: Enrolling
Updated:  5/23/2016
Staten Island University Hospital
mi
from
Staten Island, NY
Pain in Traumatic Brain Injury - Basile, MD
The Role of Persistent Pain on Neuro Psychological Functioning and Community Integration in Traumatic Brain Injury
Status: Enrolling
Updated: 5/23/2016
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy
Searching for "Sleep Friendly" Therapies for a Sleepy Population: A Double-Blind, Placebo-Controlled, Randomized Trial to Assess the Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy
Status: Enrolling
Updated:  5/25/2016
Cleveland Clinic
mi
from
Cleveland, OH
Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy
Searching for "Sleep Friendly" Therapies for a Sleepy Population: A Double-Blind, Placebo-Controlled, Randomized Trial to Assess the Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy
Status: Enrolling
Updated: 5/25/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials